Anandamide- and Δ9-tetrahydro-cannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboximide hydrochloride]

Biochemical Pharmacology

Volumn 51, Issue 5, 1996, Pages 669-676

  Shivachar, Amruthesh C ^a   Martin, Billy R ^a   Ellis, Earl F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amidohydrolase activity; Anandamide; Arachidonic acid; Astrocytes; Cannabinoid receptor antagonist; 9 tetrahydrocannabinol

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; AMIDASE; ANANDAMIDE; ARACHIDONIC ACID; BENZYLSULFONYL FLUORIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; ENZYME INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; RADIOISOTOPE; RIMONABANT; THIOMERSAL; AMIDE; ARACHIDONIC ACID DERIVATIVE; BORDETELLA VIRULENCE FACTOR; CANNABINOID; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; TETRAHYDROCANNABINOL;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG METABOLISM; ENZYME ACTIVITY; MONOLAYER CULTURE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; ASTROCYTES; CANNABINOIDS; CELLS, CULTURED; PERTUSSIS TOXIN; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; TETRAHYDROCANNABINOL; VIRULENCE FACTORS, BORDETELLA;

EID: 0029670378     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(95)02248-1     Document Type: Article

References (33)

1. 9-tetrahydrocannabinol and other cannabinoids. Biochem Pharmacol 27: 1275-1280, 1978.
2. Burstein S and Hunter SA, Prostaglandins and cannabis - VIII: Elevation of phospholipase A2 activity by cannabinoids in whole cells and subcellular preparations. J Clin Pharmacol 21: 240S-248S, 1981.
3. 9-tetrahydrocannabinol and cannabidiol on phospholipase and other enzymes regulating arachidonate metabolism. Prostaglandins Med 4: 409-411, 1980.
4. Diaz S, Specter S, Vanderhoek JY and Coffey RG, The effect of delta-9-tetrahydrocannabinol on arachidonic acid metabolism in human peripheral blood mononuclear cells. J Pharmacol Exp Ther 268: 1289-1296, 1994.
5. Howlett AC, Bidaut-Russell M, Devane WA, Melvin LS, Johnson MR and Herkenham M, The cannabinoid receptor: Biochemical, anatomical and behavioral characterization. Trends Neurosci 13: 420-423, 1990.
6. 9-Tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices. Mol Pharmacol 34: 823-828, 1988.
7. Audette CA, Burstein SH, Doyle SA and Hunter SA, G-protein mediation of cannabinoid-induced phospholipase activation. Pharmacol Biochem Behav 40: 559-563, 1991.
8. Burstein S, Budrow J, Debatis M, Hunter SA and Subramanian A, Phospholipase participation in cannabinoid-induced release of free arachidonic acid. Biochem Pharmacol 48: 1253-1264, 1994.
9. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R, Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
10. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R and Martin BR, The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270: 219-227, 1994.
11. Fride E and Mechoulam R, Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 231: 313-314, 1993.
12. Vogel Z, Barg J, Levy R, Saya D, Heldman E and Mechoulam R, Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61: 352-355, 1993.
13. Mackie K, Devane WA and Hille B, Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44: 498-503, 1993.
14. Romero J, Garcia L, Ramos JA and Fernândez-Ruiz JJ, The putative cannabinoid receptor ligand, anandamide, stimulates hypothalamic tyrosine hydroxylase activity and inhibits prolactin release. Neuroendocrinol Lett 16: 159-164, 1994.
15. Wartmann M, Campbell D, Subramanian A and Burstein SH, The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 359: 133-136, 1995.
16. Deutsch DG and Chin SA, Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46: 791-796, 1993.
17. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC and Le Fur G, SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244, 1994.
18. Amruthesh SC, Boerschel MF, McKinney JS, Willoughby KA and Ellis EF, Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes. J Neurochem 61: 150-159, 1993.
19. Volterra A, Trotti D, Cassutti P, Thromba C, Salraggio A, Melcangi RC and Racagni G, High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J Neurochem 59: 600-606, 1992.
20. Shivachar AC, Willoughby KA and Ellis EF, Effect of protein kinase C modulators on 14,15-epoxyeicosatrienoic acid incorporation into astroglial phospholipids. J Neurochem 65: 338-346, 1995.
21. Desarnaud F, Cadas H and Piomelli D, Anandamide amidohydrolase activity in rat brain microsomes. J Biol Chem 270: 6030-6035, 1995.
22. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR and Martin BR, Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265: 218-226, 1993.
23. Hunter SA, Burstein S and Sedor C, Stimulation of prostaglandin synthesis in WI-38 human lung fibroblasts following inhibition of phospholipid acylation by p-hydroxymercuribenzoate. Biochim Biophys Acta 793: 202-212, 1984.
24. Burstein S, Hunter SA, Ozman K and Renzulli L, Prostaglandins and cannabis-XIII: Cannabinoid-induced elevation of lipoxygenase products in mouse peritoneal macrophages. Biochem Pharmacol 33: 2653-2656, 1984.
25. Lu R, Hubbard JR, Martin BR and Kalimi MY, Roles of sulfhydryl and disulfide groups in the binding of CP-55,940 to rat brain cannabinoid receptor. Mol Cell Biochem 121: 119-126, 1993.
26. Koutek B, Prestwich GD, Howlett AC, Chin SA, Salehani D, Akhavan N and Deutsch DG, Inhibitors of arachidonoyl ethanolamide hydrolysis. J Biol Chem 269: 22937-22940, 1994.
27. Di Marzo B, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J-C and Piomelli D, Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691, 1994.
28. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI, Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
29. Bouaboula M, Bourrié B, Rinaldi-Carmona M, Shire D, Le Fur G and Casellas P, Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 270: 13973-13980, 1995.
30. Mailleux P, Parmentier M and Vanderhaeghen J-J, Distribution of cannabinoid receptor messenger RNA in the human brain: An in situ hybridization histochemistry with oligonucleotides, Neurosci Lett 143: 200-204, 1992.
31. Mailleux P and Vanderhaeghen J-J, Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48: 655-668, 1992.
32. Matsuda LA, Bonner TI and Lolait SJ, Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535-550, 1993.
33. Kimelberg HK and Norenberg MD, Astrocytes. Sci Am 260: 66-76, 1989.